Top Institutions in Ophthalmology and Oncology Clinical Research
Leading academic medical centers with integrated ophthalmology and oncology departments, extensive clinical trial experience with ADCs, and active involvement in multidisciplinary consensus guideline development are recognized for expertise in this area.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC is a leader in oncology clinical trials, including ADC development, and has a dedicated ocular oncology and ophthalmology service that collaborates closely with oncology researchers to address ocular toxicities.
-
#2
Massachusetts General Hospital
Boston, MA
MGH has a strong translational research program bridging ophthalmology and oncology, with involvement in early phase ADC trials and expertise in ocular toxicity management.
-
#3
Johns Hopkins Hospital
Baltimore, MD
Johns Hopkins integrates clinical pharmacology with ophthalmology and oncology, enabling detailed study of ADC ocular toxicities and dose modification strategies.
-
#4
University of California, San Francisco Medical Center
San Francisco, CA
UCSF has a robust ocular oncology program and is actively involved in clinical trials assessing ADC therapies and their ocular side effects.
-
#5
Stanford University Medical Center
Stanford, CA
Stanford combines cutting-edge research in oncology and ophthalmology, with active involvement in ADC clinical trials and ocular toxicity assessment protocols.